Preview

Вестник хирургии имени И.И. Грекова

Расширенный поиск

МЕТАБОЛИЧЕСКИЕ ЭФФЕКТЫ БАРИАТРИЧЕСКИХ ОПЕРАЦИЙ

https://doi.org/10.24884/0042-4625-2013-172-6-104-107

Полный текст:

Об авторах

Александр Евгеньевич Неймарк
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Юрий Иванович Седлецкий
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Кристина Александровна Анисимова
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Список литературы

1. Крапивина Н. А., Артымук Н. В., Тачкова О. А. Влияние некоторых гормонов пищевого поведения на репродуктивную функцию у женщин с ожирением // Вестн. НГ. Серия: биология и клиническая медицина. 2007. Вып. 3.

2. Кучер А. Г., Смирнов А. В., Каюков И. Г. и др. Лептин — новый гормон жировой ткани: значение в развитии ожирения, патологии сердечно-сосудистой системы и почек // Нефрология. 2005. № 1. С. 9–19.

3. Aprahamian T.A., Sam F. Adiponectin in cardiovascular inflammation and obesity // Int. J. Inflammation. 2011. Vol. 10. P. 8.

4. Arita Y., Kihara S., Ouchi N. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity // Biochem. Biophys. Res. Commun. 1999. Vol. 257. P. 79–83.

5. Backhed F., Ding H., Wang T. et al. The gut micro- biota as an environmental factor that regulates fat storage // Proc. Natl. Acad. Sci. USA. 2004. Vol. 101. P. 15718–15723.

6. Batterham R. L., Bloom S. R. The gut hormone peptide YY regulates appetite // Ann. N.-Y. Acad. Sci. 2003. Vol. 994. P. 162–168.

7. Boey D., Sainsbury A., Herzog H. The role of peptide YY in regulating glucose homeostasis // Peptides. 2007. Vol. 28. P. 390–395.

8. Borg C. M., le Roux C. W., Ghatei M. A. et al. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels // Obes. Surg. 2007. Vol. 17. P. 1193–1198.

9. Buchan A. M., Pederson R. A., Koop I. et al. Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass // Int. J. Obes. Relat. Metab. Disord. 1993. Vol. 17. P. 109–113.

10. Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis // J. A.M. A. 2004. № 292. Р. 1724–1737.

11. Buchwald H., Estok R., Fahrbach K. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis // Am. J. Med. 2009. № 122. Р. 248–256.

12. Callahan H. S., Cummings D. E., Pepe M. S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans // J. Clin. Endocrinol. Metab. 2004. Vol. 89, № 3. P. 1319–1324.

13. Cani P. D., Delzenne N. M. The role of the gut microbiota in energy metabolism and metabolic disease // Curr. Pharm. Des. 2009. Vol. 15. P. 1546–1558.

14. Chaikomin R., Doran S., Jones L. et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects // Am. J. Physiol. Endocrinol. Metab. 2005. Vol. 289. P. 504–507.

15. Cummings D. E., Weigle D. S., Frayo R. S. et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery // New Engl. J. Med. 2002. Vol. 346, № 21. P. 1623–1630.

16. Dixon J. B., O’Brien P. E., Playfair J. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes // J. A.M. A. 2008. Vol. 299. P. 316–323.

17. Drucker D. J. The biology of incretin hormones // Cell metabolism. 2006. Vol. 3. P. 153–165.

18. Ekblad E., Sundler F. Distribution of pancreatic polypeptide and peptide YY // Peptides. 2002. Vol. 23. P. 251–261.

19. Elrick H., Stimmler L., Hlad C. J., Arai Y. Plasma insulin response to oral and intravenous glucose administration // J. Clin. Endocrinol. Metab. 1964. Vol. 24. P. 1076–1082.

20. Frühbeck G., Caballero A. D., Gil M. J. Fundus functionality and ghrelin concentrations after bariatric surgery // New Engl. J. Med. 2004. Vol. 350, № 3. P. 308–309.

21. Geloneze B., Tambascia M. A., Pareja J. C. et al. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes // Obesity Surgery. 2001. Vol. 11. P. 693–698.

22. Hildebrandt M. A., Hoffmann C., Sherrill-Mix S. A. et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity // Gastroenterology. 2009. Vol. 137. P. 1716–1724.

23. Holdstock C., Engström B. E., Öhrvall M. et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans // J. Clin. Endocrinol. Metabolism. 2003. Vol. 88, № 7. P. 3177–3183.

24. Holst J. J. The physiology of glucagon-like peptide 1 // Physiological rev. 2007. Vol. 87. P. 1409–1439.

25. Karamanakos S. N., Vagenas K., Kalfarentzos F. et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study // Ann. Surgery. 2008. Vol. 247, № 3. P. 401–407.

26. Kim J. Y., De Wall E. Van, Laplante M. et al. Obesity associated improvements in metabolic profile through expansion of adipose tissue // J. Clin. Investigation. 2007. Vol. 117, № 9. P. 2621–2637.

27. Konstantinides S., Schafer K. et al. Leptin_dependent aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity // J. Clin. Invest. 2001. Vol. 8. P. 1533–1540.

28. Langer F.B., Hoda M. A., Bohdjalian A. et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels // Obesity Surgery. 2005. Vol. 15, №.7. P. 1024–1029.

29. Le Roux C. W., Aylwin S. J. B., Batterham R. L. et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters // Ann. Surgery. 2006. Vol. 243, № 1. P. 108–114.

30. Ley R. E., Backhed F., Turnbaugh P. et al. Obesity alters gut microbial ecology // Proc. Natl. Acad. Sci. U. S.A. 2005. Vol. 102. P. 11070–11075.

31. Ley R. E., Bäckhed F., Turnbaugh P. et al. Obesity alters gut microbial ecology // Proc. Nat. Acad. Sci. 2005. Vol. 102. P. 11070–11075.

32. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity // Nature. 2006. Vol. 444. P. 1022–1023.

33. Lin E., Gletsu N., Fugate K. et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese // Arch. Surgery. 2004. Vol. 139, № 7. P. 780–784.

34. Maeda N., Shimomura I., Kishida K. et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 // Nat. Med. 2002. Vol. 8, № 7. P. 731–737.

35. Montague C. T., Prins J., Sanders B. et al. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution // Diabetes. 1997. Vol. 46. P. 342–347.

36. Nijhuis J., Dielen F. M.H., Buurman W. A. et al. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study // Obesity Surgery. 2004. Vol. 14, № 6. P. 783–787.

37. Pories W. J., Macdonald K. G., Morgan E. J. et al. Surgical treatment of obesity and its effect on diabetes: 10-year follow-up // Am. J. Clin. Nutr. 1992. Vol. 55. P. 582–591.

38. Sam F., Duhaney T.A., Sato K. et al. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure // Endocrinology. 2010. Vol. 151, № 1. Р. 322–331.

39. Shibata R., Ouchi N., Kihara S. et al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling // J. Biol. Chemistry. 2004. Vol. 279. № 27. P. 28670–28674.

40. Stoeckli R., Clianda R., Langer I. et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass // Obesity Research. 2004. Vol. 12, № 2. P. 346–350.

41. Strader A. D., Woods S. C. Gastrointestinal hormones and food intake // Gastroenterology. 2005. Vol. 128. P. 175–191.

42. Tschop M., Smiley D. L. Ghrelin plasma levels // Diabetes. 2001. Vol. 50. Р. 707–709.

43. Toouli J., Fried M., Khan A. G. et al. Global guideline obesity. World Gastroenter. Organization. 2009. P. 26–42.

44. Turnbaugh P. J., Backhed F., Fulton L. et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome // Cell Host. Microbe. 2008. Vol. 3. P. 213–223.

45. Turnbaugh P. J., Hamady M., Yatsunenko T. et al. A core gut microbiome in obese and lean twins // Nature. 2009. Vol. 457. P. 480–484.

46. Turnbaugh P. J., Ridaura V. K., Faith J. J. et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnoto- biotic mice // Sci. Transl. Med. 2009. Vol. 1. P. 6–14.

47. Valverde I., Villanueva-Penacarrillo M. L., Malaisse W. J. Pancreatic and extrapancreatic effects of GLP-1 // Diabetes Metab. 2002. Vol. 28. P. 85–89.

48. Vincent R. P., le Roux C. W. Changes in gut hormones after bariatric surgery // Clin. Endocrinol. 2008. Vol. 69. P. 173–179.

49. Woelnerhanssen B., Peterli R., Steinert R. E. et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy — a prospective randomized trial // Surg. Obesity and Related Diseases. 2011. Vol. 7. P. 561–568.

50. Zhanga H., DiBaiseb J. K., Zuccoloc A. et al. Human gut microbiota in obesity and after gastric bypass // PNAS. 2009. Vol. 106, № 7. P. 2365–2370.


Для цитирования:


Неймарк А.Е., Седлецкий Ю.И., Анисимова К.А. МЕТАБОЛИЧЕСКИЕ ЭФФЕКТЫ БАРИАТРИЧЕСКИХ ОПЕРАЦИЙ. Вестник хирургии имени И.И. Грекова. 2013;172(6):104-107. https://doi.org/10.24884/0042-4625-2013-172-6-104-107

Просмотров: 99


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0042-4625 (Print)
ISSN 2686-7370 (Online)